ONCO — Oncopeptides AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Oncopeptides AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	840	362	345	173	179
Net Total Accounts Receivable
Net Total Receivables	23.2	38	17.3	17.9	13.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	895	412	364	203	217
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	38.3	24.7	20.4	34.6	27.1
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	947	439	385	238	244
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	354	225	85.7	44.9	51.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	370	229	91	182	190
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	577	211	294	56.8	54.3
Total Liabilities & Shareholders' Equity	947	439	385	238	244
Total Common Shares Outstanding